Article date: March 2007
By: Peter A. G. M. De Smet, in Volume 63, Issue 3, pages 258-267
The concomitant use of conventional and herbal medicines can lead to clinically relevant herb–drug interactions. Clinical risk management offers a systematic approach to minimize the untoward consequences of these interactions by paying attention to: (i) risk identification and assessment; (ii) development and execution of risk reduction strategies; and (iii) evaluation of risk reduction strategies. This paper reviews which steps should be explored or taken in these domains to improve the clinical risk management of adverse herb–drug interactions.
DOI: 10.1111/j.1365-2125.2006.02797.x
View this article